• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.对含有阿片类药效基团Dmt-Tic的先导化合物的进一步研究。
J Med Chem. 2008 Aug 28;51(16):5109-17. doi: 10.1021/jm800587e. Epub 2008 Aug 5.
2
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.Dmt-Tic阿片类药物药效基团C末端赖氨酸的作用。
J Med Chem. 2006 Sep 7;49(18):5610-7. doi: 10.1021/jm060741w.
3
Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.Dmt-Tic药效团的评估:将一种强效δ-阿片受体拮抗剂转化为强效δ-激动剂以及具有混合性质的配体。
J Med Chem. 2002 Jan 31;45(3):713-20. doi: 10.1021/jm010449i.
4
Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore.含有Dmt-Tic药效基团的强效δ-阿片受体激动剂。
J Med Chem. 2002 Dec 5;45(25):5556-63. doi: 10.1021/jm020336e.
5
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.Dmt-Tic药效团中C末端取代氨基酸对δ-阿片受体选择性和拮抗作用的直接影响。
J Med Chem. 2004 Jul 29;47(16):4066-71. doi: 10.1021/jm040033f.
6
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism.对Dmt-Tic药效基团的进一步研究:C末端的疏水取代基赋予δ拮抗剂表现出μ激动或μ拮抗作用。
J Med Chem. 1999 Dec 2;42(24):5010-9. doi: 10.1021/jm990165m.
7
N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.TIPP(Tyr-Tic-Phe-Phe)肽的 N-末端胍基化导致阿片活性谱的重大变化。
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5082-5. doi: 10.1016/j.bmcl.2013.07.036. Epub 2013 Jul 23.
8
Bioactivity of new mu and delta opioid peptides.新型μ和δ阿片肽的生物活性
Med Chem. 2007 Sep;3(5):480-7. doi: 10.2174/157340607781745429.
9
Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).苯并咪唑(Bid)在δ-阿片受体激动剂假肽H-Dmt-Tic-NH-CH(2)-Bid(UFP-502)中的作用
Bioorg Med Chem. 2008 Mar 15;16(6):3032-8. doi: 10.1016/j.bmc.2007.12.032. Epub 2007 Dec 23.
10
Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.δ阿片样物质模拟拮抗剂:设计新一代超选择性阿片肽的原型
Mol Med. 1995 Sep;1(6):678-89.

引用本文的文献

1
Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour.新型阿片类配体UTA1003对镇痛耐受性和运动行为的不同影响。
Pharmaceuticals (Basel). 2022 Jun 24;15(7):789. doi: 10.3390/ph15070789.
2
Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show Kappa and Mu Opioid Receptor Agonism.新型含芳香四氢异喹啉取代基的二甲基酪氨酸-四氢异喹啉肽拟似物具有 κ 和 μ 阿片受体激动活性。
ACS Chem Neurosci. 2019 Aug 21;10(8):3682-3689. doi: 10.1021/acschemneuro.9b00250. Epub 2019 Jul 1.
3
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated.δ阿片类激动剂UFP-512治疗可减轻慢性炎症性和神经性疼痛:相关机制
Front Pharmacol. 2019 Mar 26;10:283. doi: 10.3389/fphar.2019.00283. eCollection 2019.
4
A DFT and semiempirical model-based study of opioid receptor affinity and selectivity in a group of molecules with a morphine structural core.基于密度泛函理论(DFT)和半经验模型对一组具有吗啡结构核心的分子中阿片受体亲和力和选择性的研究。
Int J Med Chem. 2012;2012:682495. doi: 10.1155/2012/682495. Epub 2012 Dec 13.
5
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues.内吗啡肽-2 杂合类似物的合成、药理学评价及构象研究。
Mol Divers. 2013 Feb;17(1):19-31. doi: 10.1007/s11030-012-9399-5. Epub 2012 Nov 4.
6
Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds.2',6'-二甲基-l-酪氨酸(Dmt)在一些阿片样物质先导化合物中的作用。
Bioorg Med Chem. 2010 Aug 15;18(16):6024-30. doi: 10.1016/j.bmc.2010.06.073. Epub 2010 Jun 25.
7
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds.基于 4-氨基苯并氮杂卓(Aba)、氮杂吲哚(Aia)和四氢异喹啉(Tic)骨架的新型多阿片配体。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1610-3. doi: 10.1016/j.bmcl.2010.01.055. Epub 2010 Jan 20.

本文引用的文献

1
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.修饰型内吗啡肽1肽库的合成及体外评价
Bioorg Med Chem. 2008 Jun 1;16(11):6286-96. doi: 10.1016/j.bmc.2008.04.020. Epub 2008 Apr 15.
2
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.重新定义2,6-亚甲基-3-苯并氮杂卓的构效关系。第6部分:8-羧酰胺环佐辛环类似物的阿片受体结合特性
Bioorg Med Chem. 2008 May 15;16(10):5653-64. doi: 10.1016/j.bmc.2008.03.066. Epub 2008 Mar 30.
3
Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling.Src通过干扰受体再循环促进δ阿片受体(DOR)脱敏。
J Cell Mol Med. 2009 Jan;13(1):147-63. doi: 10.1111/j.1582-4934.2008.00308.x. Epub 2008 Mar 19.
4
Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.一种源自Dmt-Tic药效基团的用于正电子发射断层扫描成像的强效且选择性的(18)F标记的δ阿片受体拮抗剂的合成。
J Med Chem. 2008 Mar 27;51(6):1817-23. doi: 10.1021/jm7014765. Epub 2008 Mar 1.
5
Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation.CXCR4/δ-阿片受体异二聚体的配体稳定作用揭示了一种免疫反应调节机制。
Eur J Immunol. 2008 Feb;38(2):537-49. doi: 10.1002/eji.200737630.
6
Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.μ和δ阿片受体作为受体-G蛋白融合体的共表达通过不同机制增强了μ和δ信号传导。
J Neurochem. 2008 May;105(3):865-73. doi: 10.1111/j.1471-4159.2008.05215.x. Epub 2008 Jan 7.
7
Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).苯并咪唑(Bid)在δ-阿片受体激动剂假肽H-Dmt-Tic-NH-CH(2)-Bid(UFP-502)中的作用
Bioorg Med Chem. 2008 Mar 15;16(6):3032-8. doi: 10.1016/j.bmc.2007.12.032. Epub 2007 Dec 23.
8
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.新型选择性δ阿片受体激动剂H-Dmt-Tic-NH-CH(CH2-COOH)-Bid(UFP-512)的抗焦虑和抗抑郁样活性
Peptides. 2008 Jan;29(1):93-103. doi: 10.1016/j.peptides.2007.10.012. Epub 2007 Oct 23.
9
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.新型选择性δ阿片受体激动剂UFP-512的体外和体内药理学特性;脱敏与耐受性之间的相关性
Br J Pharmacol. 2007 Dec;152(8):1312-24. doi: 10.1038/sj.bjp.0707497. Epub 2007 Nov 5.
10
Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.开发在μ和δ阿片受体上均具有增强阿片活性的新型脑啡肽类似物。
J Med Chem. 2007 Nov 1;50(22):5528-32. doi: 10.1021/jm061465o. Epub 2007 Oct 10.

对含有阿片类药效基团Dmt-Tic的先导化合物的进一步研究。

Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.

作者信息

Balboni Gianfranco, Fiorini Stella, Baldisserotto Anna, Trapella Claudio, Sasaki Yusuke, Ambo Akihiro, Marczak Ewa D, Lazarus Lawrence H, Salvadori Severo

机构信息

Department of Toxicology, University of Cagliari, I-09124 Cagliari, Italy.

出版信息

J Med Chem. 2008 Aug 28;51(16):5109-17. doi: 10.1021/jm800587e. Epub 2008 Aug 5.

DOI:10.1021/jm800587e
PMID:18680274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2812024/
Abstract

Some reference opioids containing the Dmt-Tic pharmacophore, especially the delta agonists H-Dmt-Tic-Gly-NH-Ph (1) and H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid (4) (UFP-512) were evaluated for the influence of the substitution of Gly with aspartic acid, its chirality, and the importance of the -NH-Ph and N(1)H-Bid hydrogens in the inductions of delta agonism. The results provide the following conclusions: (i) Asp increases delta selectivity by lowering the mu affinity; (ii) -NH-Ph and N(1)H-Bid nitrogens methylation transforms the delta agonists into delta antagonists; (iii) the substitution of Gly with L-Asp/D-Asp in the delta agonist H-Dmt-Tic-Gly-NH-Ph gave delta antagonists; the same substitution in the delta agonist H-Dmt-Tic-NH-CH2-Bid yielded more selective agonists, H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid and H-Dmt-Tic-NH-(R)CH(CH2-COOH)-Bid; (iv) L-Asp seems important only in functional bioactivity, not in receptor affinity; (v) H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid(N(1)-Me) (10) evidenced analgesia similar to 4, which was reversed by naltrindole only in the tail flick. 4 and 10 had opposite behaviours in mice; 4 caused agitation, 10 gave sedation and convulsions.

摘要

对一些含有Dmt-Tic药效基团的参考阿片类药物,特别是δ激动剂H-Dmt-Tic-Gly-NH-Ph(1)和H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid(4)(UFP-512),评估了用天冬氨酸取代甘氨酸、其手性以及-NH-Ph和N(1)H-Bid氢原子在诱导δ激动作用中的重要性。结果得出以下结论:(i)天冬氨酸通过降低μ亲和力提高δ选择性;(ii)-NH-Ph和N(1)H-Bid氮原子甲基化将δ激动剂转变为δ拮抗剂;(iii)在δ激动剂H-Dmt-Tic-Gly-NH-Ph中用L-天冬氨酸/D-天冬氨酸取代甘氨酸得到δ拮抗剂;在δ激动剂H-Dmt-Tic-NH-CH2-Bid中进行相同取代产生了选择性更高的激动剂H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid和H-Dmt-Tic-NH-(R)CH(CH2-COOH)-Bid;(iv)L-天冬氨酸似乎仅在功能生物活性方面重要,在受体亲和力方面不重要;(v)H-Dmt-Tic-NH-(S)CH(CH2-COOH)-Bid(N(1)-Me)(10)表现出与4相似的镇痛作用,仅在甩尾试验中被纳曲吲哚逆转。4和10在小鼠中表现出相反的行为;4引起躁动,10导致镇静和惊厥。